Macitentan for the treatment of pulmonary arterial hypertension

Overview of attention for article published in Vascular Health and Risk Management, November 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

patent: 7 patents

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 94 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 7 patents that reference this research output.

DISPERSIBLE TABLET FOR ORAL ADMINISTRATION

Application WO-2022258796-A1

World Intellectual Property Organisation (WIPO)

Pharmaceutical composition for the treatment of pulmonary arterial hypertension

Grant US-11464777-B2

United States of America

METHODS FOR TREATING PULMONARY HYPERTENSION IN PATIENTS WITH LEFT VENTRICULAR ASSIST…

Application WO-2022180194-A1

World Intellectual Property Organisation (WIPO)

Pharmaceutical composition for treating pulmonary hypertension

Application CN-113194953-A

China

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PULMONARY VASCULAR DISEASE AND/OR CARDIAC…

Application WO-2021105164-A1

World Intellectual Property Organisation (WIPO)

PHARMACEUTICAL COMPOSITION COMPRISING MACITENTAN FOR THE TREATMENT OF CHRONIC…

Application WO-2020152308-A1

World Intellectual Property Organisation (WIPO)

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

Application WO-2020128017-A1

World Intellectual Property Organisation (WIPO)